Department of Anaesthesiology and Reanimation, Division of Intensive Care Medicine, Izmir Tepecik Training and Research Hospital, Konak / Izmir, Turkiye.
Department of Nephrology, Division of Internal Medicine, Izmir Tepecik Training and Research Hospital, Konak / Izmir, <br> Turkiye.
J Coll Physicians Surg Pak. 2024 Aug;34(8):993-995. doi: 10.29271/jcpsp.2024.08.993.
This retrospective study was conducted at the Izmir Tepecik Training and Research Hospital from January 2020 to December 2021. It aimed to determine acute kidney injury (AKI) frequency and associated factors in critically ill COVID-19 patients. Out of 177 patients, 49.7% developed AKI, with an average onset of 7.63 days. AKI stages varied, and progression occurred in 27 patients within 48 hours. ICU and hospital mortality rates were significantly higher in AKI patients (86.4% and 92%, respectively) compared to non-AKI patients (19.1% and 22.5%). The study highlights age, sequential organ failure assessment (SOFA) score, and nephrotoxic agent presence as significant factors influencing AKI development in COVID-19 patients. Key Words: Critical care unit, COVID-19, Acute kidney failure.
本回顾性研究于 2020 年 1 月至 2021 年 12 月在伊兹密尔 Tepecik 培训与研究医院进行，旨在确定危重症 COVID-19 患者中急性肾损伤（AKI）的发生率及其相关因素。在 177 例患者中，49.7%发生 AKI，平均发病时间为 7.63 天。AKI 分期不同，27 例患者在 48 小时内发生进展。AKI 患者的 ICU 死亡率和住院死亡率（分别为 86.4%和 92%）显著高于非 AKI 患者（分别为 19.1%和 22.5%）。本研究强调了年龄、序贯器官衰竭评估（SOFA）评分和肾毒性药物的存在是影响 COVID-19 患者 AKI 发展的重要因素。关键词：重症监护病房、COVID-19、急性肾衰竭。
